Patient-Reported Outcomes During and After Treatment for Locally Advanced Rectal Cancer in the PROSPECT Trial (Alliance N1048)
Ethan Basch(UNC Lineberger Comprehensive Cancer Center), Deborah Schrag(Memorial Sloan Kettering Cancer Center), Sandra A. Mitchell(University of North Carolina at Chapel Hill), Thomas J. George(University of Florida Health), Jeffrey A. Meyerhardt(CancerCare), Andrea Denicoff(National Cancer Institute), Leonard B. Saltz(Roswell Park Comprehensive Cancer Center), Lori M. Minasian(National Cancer Institute), Alan P. Venook(University of California, San Francisco), Qian Shi(Mayo Clinic), George J. Chang(The University of Texas MD Anderson Cancer Center), Benjamin Musher(Baylor College of Medicine), Gina L. Mazza(Mayo Clinic in Arizona), Marc J. Gollub(Memorial Sloan Kettering Cancer Center), Lauren J. Rogak(Memorial Sloan Kettering Cancer Center), Eileen M. O’Reilly(Memorial Sloan Kettering Cancer Center), Gita Thanarajasingam(Mayo Clinic in Arizona), Jeffrey M. Farma(Fox Chase Cancer Center), Harvey J. Mamon(Brigham and Women's Hospital), Amylou C. Dueck(Memorial Sloan Kettering Cancer Center), Brenda Ginos(Mayo Clinic in Arizona), B. Colgrove(Mayo Clinic), Martin R. Weiser(Memorial Sloan Kettering Cancer Center)
Cited by 136
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k
How To Build and Interpret a Nomogram for Cancer Prognosis
|Journal of Clinical Oncology|2008|3.4k
Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal Cancer
|New England Journal of Medicine|2000|3k
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
|New England Journal of Medicine|2012|2.8k